When small-cell lung cancer (SCLC) has spread to distant parts of the body, it’s classified as extensive-stage, which applies ...

No, but because this cancer has often spread by the time it is diagnosed, the survival rates tend to be lower than for non-small cell lung cancer (NSCLC). Treatments can prolong survival, however ...

Freida Gantt, diagnosed with a rare cancer, spent her life caring for others as a certified nursing assistant.

When non-small cell lung cancer (NSCLC) spreads beyond the lungs, it often metastasizes to the bones. Estimates suggest 20 to 30 percent of people with NSCLC have bone metastases at the time of ...

Dr. Prantesh Jain and Dr. Joshua Sabari delved into the numerous advances in NSCLC following 2025 ASCO, highlighting the ...

Tarlatamab improved PFS and OS over chemotherapy as second-line treatment in patients with SCLC in the phase 3 DeLLphi-304 trial.

During June, investigators reported new data that has advanced the treatment landscape for lung cancer, including new FDA ...

Cancer is not a welcome diagnosis, but breakthroughs in genetic sequencing and immunotherapy are making some cancers easier ...

Vaping might be safer than cigarette smoking, but they carry their own health risks. A New Jersey man’s electronic cigarette ...

A new research paper was published in Volume 16 of Oncotarget on June 17, 2025, titled "Molecular landscape of HER2-mutated ...

The publication, entitled “Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 ...